Rapid development of clone-specific, high-performing perfusion media from established feed supplements.

Patrick Mayrhofer1, David Reinhart1, Andreas Castan2

  • 1Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.

Biotechnology Progress
|November 5, 2019
PubMed
Summary

Developing clone-specific perfusion media for recombinant Chinese hamster ovary (CHO) cells significantly boosts biopharmaceutical production. This rapid, two-step method optimizes media blends, achieving high cell densities and space-time-yields (STYs).